<p>(<b>a</b>) SFT is more effective <i>in vitro</i> against HIV-1 subtype C pseudovirus than TFV. The IC<sub>50</sub> value of TFV in PBS against subtype C was 5.2 µM, whereas that of SFT in PBS was only 25.6 nM. (<b>b</b>) Efficacy of SFT in PBS or in 0.015% HEC gel to inhibit infection by HIV-1 pseudoviruses bearing the Env of CRF07_BC (upper left), CRF01_AE (upper right), B (lower left) and C (lower right), respectively. Data represent means ± SD from triplicate experiments. Student's <i>t</i>-test was performed to determine the significance of difference between various groups as shown in the graph, *<i>p</i><0.05.</p
Background: Tenofovir gel has entered into clinical trials for use as a topical microbicide to preve...
<p>Sera from 50 HIV-1 subtype A-infected patients were tested in the TZM-bl neutralization assay aga...
<p>The IC<sub>50</sub> values were estimated from the titration curves of all mAb/psV combinations a...
<p>(A) VSV-G replication assay. Serial dilutions of pseudotyped virus (VSV-G envelope) were used in ...
<p>A. Inhibition of HIV-1<sub>NL4-3</sub> Env-pseudotyped virus in single-cycle assay that demonstra...
HIV-1 Env pseudotyped viruses (PV) are an attractive tool for studying the antiviral activities of c...
<p>The fraction neutralized is plotted against the concentration of Fab sites. The inserts in A, B a...
Tenofovir gel has entered into clinical trials for use as a topical microbicide to prevent HIV-1 inf...
models. To validate our findings with on-going clinical trial results, we evaluated topical tenofov...
<p><b><i>In vitro</i> neutralization data for individual antibodies against A, C & D subtype pseudov...
<p>hMDMs were pretreated with vehicle (DMSO), 5 μM AZT, or 10 μM SFN. All cultures were subsequently...
<p>The recombinant Caulobacters were combined in equal amounts and co-incubated with one of six diff...
<p>(<b>a</b>) MTT assay was used to determine the cell viability of epithelial line Caco-2 (left) or...
Sifuvirtide is a proven effective HIV-1 entry inhibitor and its safety profile has been established ...
<p>Cc-Control, Cc-Fz, Cc-T1249 and Cc-C52 were incubated for 48 hours with TZM-bl cells and 200TCID5...
Background: Tenofovir gel has entered into clinical trials for use as a topical microbicide to preve...
<p>Sera from 50 HIV-1 subtype A-infected patients were tested in the TZM-bl neutralization assay aga...
<p>The IC<sub>50</sub> values were estimated from the titration curves of all mAb/psV combinations a...
<p>(A) VSV-G replication assay. Serial dilutions of pseudotyped virus (VSV-G envelope) were used in ...
<p>A. Inhibition of HIV-1<sub>NL4-3</sub> Env-pseudotyped virus in single-cycle assay that demonstra...
HIV-1 Env pseudotyped viruses (PV) are an attractive tool for studying the antiviral activities of c...
<p>The fraction neutralized is plotted against the concentration of Fab sites. The inserts in A, B a...
Tenofovir gel has entered into clinical trials for use as a topical microbicide to prevent HIV-1 inf...
models. To validate our findings with on-going clinical trial results, we evaluated topical tenofov...
<p><b><i>In vitro</i> neutralization data for individual antibodies against A, C & D subtype pseudov...
<p>hMDMs were pretreated with vehicle (DMSO), 5 μM AZT, or 10 μM SFN. All cultures were subsequently...
<p>The recombinant Caulobacters were combined in equal amounts and co-incubated with one of six diff...
<p>(<b>a</b>) MTT assay was used to determine the cell viability of epithelial line Caco-2 (left) or...
Sifuvirtide is a proven effective HIV-1 entry inhibitor and its safety profile has been established ...
<p>Cc-Control, Cc-Fz, Cc-T1249 and Cc-C52 were incubated for 48 hours with TZM-bl cells and 200TCID5...
Background: Tenofovir gel has entered into clinical trials for use as a topical microbicide to preve...
<p>Sera from 50 HIV-1 subtype A-infected patients were tested in the TZM-bl neutralization assay aga...
<p>The IC<sub>50</sub> values were estimated from the titration curves of all mAb/psV combinations a...